Deep Track Capital, LP Rapt Therapeutics, Inc. Put Options Transaction History
Deep Track Capital, LP
- $2.27 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RAPT
# of Institutions
99Shares Held
78.4MCall Options Held
213KPut Options Held
16.9K-
Medicxi Ventures Management (Jersey) LTD22.4MShares$26.6 Million7.76% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$14.9 Million8.8% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$14 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.94MShares$3.5 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$3.19 Million7.75% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $35.3M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...